New Age Alpha Advisors, LLC Biogen Inc. Transaction History
New Age Alpha Advisors, LLC
- $2.27 Trillion
- Q2 2025
A detailed history of New Age Alpha Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, New Age Alpha Advisors, LLC holds 1,132 shares of BIIB stock, worth $144,896. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,132
Previous 1,110
1.98%
Holding current value
$144,896
Previous $152 Million
6.4%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
1,015Shares Held
126MCall Options Held
2.31MPut Options Held
4.26M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.21 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.02 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$1.86 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.4MShares$947 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.67MShares$598 Million0.13% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $18.4B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...